| PRD_000348 | Name: | N~1~-{(1S,2S,4S)-1-(cyclohexylmethyl)-4-[(2,2-dimethylpropyl)carbamoyl]-2-hydroxy-5-methylhexyl}-N~2~-(quinolin-2-ylcar
bonyl)-L-aspartamide | Formula: | C34 H51 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000349 | Name: | N-[(2R)-2-({N~5~-[amino(iminio)methyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucinamide | Formula: | C40 H70 N11 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000350 | Name: | SUCCINYL-ALA-ALA-PRO-LYS | Formula: | C21 H36 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000351 | Name: | SUCCINYL-ALA-ALA-PRO-ARG | Formula: | C21 H36 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000352 | Name: | N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-L-prolyl-6-ammonio-N-(4-nitrophenyl)-L-norleucinamide | Formula: | C27 H40 N7 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000353 | Name: | (2S)-2-[(2-amino-1,3-thiazol-4-yl)methyl]-N~1~-{(1S,2S)-1-(cyclohexylmethyl)-2-hydroxy-2-[(3R)-1,5,5-trimethyl-2-oxopyrrolidin-3-yl]ethyl}-N~4~-[2-(dimethylamino)-2-oxoethyl]-N~4~-[(1S)-1-phenylethyl]butanediamide | Formula: | C36 H54 N6 O5 S | Definition date: | 2012-12-12 | Last modified: | 2022-03-02 |
|
| PRD_000354 | Name: | SUCCINYL-GLN-VAL-VAL-ALA-ALA-P-NITROANILIDE | Formula: | C31 H46 N8 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000355 | Name: | N~2~-{(2S)-2-[(N-acetyl-4-carbamimidoyl-L-phenylalanyl)amino]-2-cyclohexylacetyl}-N~6~,N~6~-dimethyl-L-lysyl-
L-leucyl-L-prolinamide | Formula: | C39 H63 N9 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000356 | Name: | N-[(1S)-2-{[(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl]amino}-1-(ethylsulfanyl)-2-oxoethyl]-Nalpha-(morp
holin-4-ylsulfonyl)-L-phenylalaninamide | Formula: | C31 H52 N4 O7 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000357 | Name: | 3-methyl-L-valyl-L-prolyl-L-isoleucine | Formula: | C17 H31 N3 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000358 | Name: | (1R)-1-benzyl-1-methyl-1-(2-{[4-(1-methylethyl)phenyl]amino}-2-oxoethyl)-2-{(2S)-4-methyl-2-[(trifluoroacetyl)amino]pentanoyl}diazanium | Formula: | C27 H36 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000360 | Name: | N-(trifluoroacetyl)-L-valyl-N-[4-(trifluoromethyl)phenyl]-L-alaninamide | Formula: | C17 H19 F6 N3 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000361 | Name: | N~2~-[(2R)-2-benzyl-3-(tert-butylsulfonyl)propanoyl]-N-{(1R)-1-(cyclohexylmethyl)-3,3-difluoro-2,2-dihydroxy-4-[(2-morpholin-4-ylethyl)amino]-4-oxobutyl}-3-(1H-imidazol-3-ium-4-yl)-L-alaninamide | Formula: | C36 H56 F2 N7 O8 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000362 | Name: | INHIBITOR VAL-SER-GLN-ASN-LEU-PSI(CH(OH)-CH2)-VAL-ILE-VAL (U-85548E) | Formula: | C40 H73 N9 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000363 | Name: | Ace-LEALFQ-ethylpropionate | Formula: | C40 H63 N7 O11 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000364 | Name: | N-(trifluoroacetyl)-L-phenylalanyl-N-[4-(trifluoromethyl)phenyl]-L-alaninamide | Formula: | C21 H19 F6 N3 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000365 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-prolinamide | Formula: | C22 H32 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000366 | Name: | N-(trifluoroacetyl)-L-leucyl-N-[4-(trifluoromethyl)phenyl]-L-alaninamide | Formula: | C18 H21 F6 N3 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000367 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-phenylalaninamide | Formula: | C26 H34 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000368 | Name: | 6-ammonio-N-(trifluoroacetyl)-L-norleucyl-N-[4-(1-methylethyl)phenyl]-L-leucinamide | Formula: | C23 H36 F3 N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000369 | Name: | D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | Formula: | C25 H36 Cl N6 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000370 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-hydroxy-L-alaninamide | Formula: | C17 H25 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000371 | Name: | N-benzyl-N~2~-[(2R)-2-(hydroxycarbamoyl)-4-methylpentanoyl]-L-alpha-asparagine | Formula: | C18 H25 N3 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000372 | Name: | (3R)-2-[N-(furan-2-ylcarbonyl)-L-leucyl]-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylic acid | Formula: | C23 H25 N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000374 | Name: | 3-[(2S)-2-{[(4-methylphenyl)sulfonyl]amino}-3-oxo-3-piperidin-1-ylpropyl]benzenecarboximidamide | Formula: | C22 H28 N4 O3 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|